47 results about "Her Disease" patented technology

A system and method for endoluminal grafting of a main anatomic conduit in its diseased state in which it dilates to pose a life threatening condition and its various conduits that emanate from the main anatomic conduit. The grafting system comprises an endoaortic graft having at least one opening therein and at least one branch graft that is passable through the opening of the endoaortic graft into the branch anatomic conduit(s) such that the junction between the branch graft and the endoaortic graft is substantially fluid tight. A system and method for delivery of the endoaortic graft and also a system and method for efficient alignment and deployment of the branch (e.g., side branch) graft such that the coupling of the branch graft with the endoaortic graft is efficient and exact and fluid-tight; and a system and method for coupling the branch to the endoaortic graft via a coupling mechanism employing a memory metal alloy; a system and method for the proper and exact alignment of the endoaortic graft and the branch using magnetic force of a suitable nature, and which does not use the magnetic force as the coupling mechanism.

The invention discloses a method by which the health care professional or patient may draw upon historical medical data concerning patients similarly situated in medical condition, to assist him / her in deciding on a clinical intervention procedure to select. This method is specifically tailored to the patient, as data is provided and evaluated from only similarly situated patients, and provides an expectation of potential outcome of the patient should one or the other of the options be selected. The invention further provides a database that may be used in order to provide this comparison based evaluation method. A computer based software system is further disclosed that implements the method. The invention more speiocifically provides a method by which a post-coronary event patient may make an informed decision of which post-coronary revascularization procedure to undergo in the future management of his disease. This method employs the patient's health status date (symptoms, function and quality of life), and provides projections of the patient's expected survival, risk, and 1-year health status outcome from the selection of revascularization procedure, such as Coronary Artery Bypass Grafting (CABG) or Percutaneous Coronary Intervention (PCI).

A computerized system allows intercommunication of patients with respect to the treatment of their diseases. This system includes an electronic medical record database providing electronic medical records of a given set of patients as developed by healthcare professionals and linked to an anonymous identifier for each patient and a set of terminal devices accessible to the patients allowing for the electronic exchange of information through a display and data input device. A server system connects the anonymous medical record database and the terminal devices and executes a stored program to: (1) allow an authenticated connection by a given patient to the server system through a terminal device and associate the connection with an anonymous identifier; (2) permit authoring by the given patient of a patient site viewable on a terminal device incorporating medical records from the anonymous medical record database associated with the anonymous identifier; and (3) identify to the given patient other patient sites for other patients having shared medical conditions according to a predetermined clustering of data of the anonymous medical record database.

Systems and methods for treating gastroesophageal reflux disease (GERD) includes minimally invasively implanting a stimulating device in a patient's esophagus in the region proximate the lower esophageal sphincter (LES). The patient is provided with a questionnaire related to his disease via an online service. The questionnaire is accessed on a mobile device, such as a cell phone, or on a computer with network access. The data from the sensors and the answers from the questionnaire are analyzed together by a health care provider using the online service. The data and answers are used to program the stimulating device, via the mobile device or computer, to optimize treatment.

The present invention describes clinically and medically important methods of examining, screening over time, and monitoring the outcome of a cancer patient who is undergoing treatment or therapy for his or her disease. More specifically, the invention provides a method of monitoring the progression of disease, or the effectiveness of cancer treatment, in a cancer patient by measuring the levels of one or more analytes of the plasminogen activator (uPA) system, namely, uPA, PAI-1 and the complex of uPA:PAI-1, in a sample taken from the cancer patient, preferably, before treatment, at the start of treatment, and at various time intervals during treatment. As a result of performing the method, an increase or elevation in the levels of one or more of the PA system analytes in the cancer patient compared with the levels one or more of the respective PA system analytes in normal control individuals serves as an indicator of cancer advancement or progression and / or a lack of treatment effectiveness for the patient.